Delivery Order SPE2DR25D2108-SPE2DR26F6RH3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,771.49 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on December 5, 2025, with completion targeted for December 8, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $1,750.74 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $11,456.09 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,846.39 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in a quantity of 100 units. This competitive award, issued on December 1, 2025, with an ultimate completion date of December 2, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units at a ceiling value of $1,606.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a $2,977.70 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,210.66 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 MG tablets (100-count units) under a firm fixed-price contract. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025, and does not utilize a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a $1,119.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a diabetes medication. The delivery order, issued on October 31, 2025, requires completion by November 3, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. This award was made without a set-aside designation, indicating it was competitively awarded through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.55 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100, with an ultimate completion date of October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100, with a contract value of $9,136.01 and a completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6RH3Delivery Order
The Defense Logistics Agency awarded a $2,459.72 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg on December 3, 2025, with completion required by December 4, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor at its Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the company's extensive federal pharmaceutical supply portfolio. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply critical medical commodities including brand-name and generic medications, vaccines, and specialized medical supplies to military healthcare programs worldwide. The current Glimepiride order supports the company's ongoing role as a key vendor for federal medical procurement needs across military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/2/25 |